Inhibition of HIV-1 integrase-catalysed reaction by new DNA minor groove ligands: the oligo-1,3-thiazolecarboxamide derivatives.
Eur J Med Chem
; 35(11): 989-1000, 2000 Nov.
Article
in En
| MEDLINE
| ID: mdl-11137227
ABSTRACT
Human immunodeficiency virus type 1 (HIV-1) integrase (IN) is an essential enzyme in the life cycle of the retrovirus, responsible for catalysing the insertion of the viral genome into the host cell chromosome. For this reason it provides an attractive target for antiviral drug design. We synthesized a series of novel thiazole (Tz)-containing oligopeptides (TCOs; oligo-1,3-thiazolecarboxamides), specifically interacting within the minor groove of DNA. The oligocarboxamide derivatives contained 1-4 Tz rings and different N- and C-terminal groups. The effect of these oligocarboxamides on the HIV-1 IN-catalysed reaction was investigated. Some of the compounds were able to inhibit the reaction. The inhibitory effect of the TCOs increased with the number of Tz units. The structure of various additional positively and/or negatively charged groups attached to the N- and C-termini of TCOs had a pronounced effect on their interaction with the DNA substrate complexed to IN. Modified TCOs having a better affinity for this complex should provide a rationale for the design of drugs targeting the integration step.
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Thiazoles
/
DNA, Viral
/
HIV-1
/
HIV Integrase Inhibitors
Language:
En
Journal:
Eur J Med Chem
Year:
2000
Document type:
Article
Affiliation country:
RUSSIA